Upgrade to SI Premium - Free Trial

Unicycive Therapeutics (UNCY) PT Lowered to $37 at Guggenheim

May 13, 2026 6:38 AM
(Updated - May 13, 2026 6:51 AM EDT)

Guggenheim analyst Vamil Divan lowered the price target on Unicycive Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change